- Solid-Phase Synthesis of Symmetrical 5',5'-Dinucleoside Mono-, Di-, Tri-, and TetraphosphodiestersBy Ahmadibeni, Yousef and Parang, Keykavous, Organic Letters, 2007, 9(22), 4483-4486
Cas no 5959-90-0 (Adenosine-(5')-triphospho-(5')-adenosine)
Adenosine-(5')-triphospho-(5')-adenosine (Ap?A) is a dinucleotide consisting of two adenosine moieties linked by a triphosphate bridge. This compound plays a significant role in cellular signaling and energy metabolism, serving as a substrate for various enzymes, including nucleotide pyrophosphatases and ligases. Its structural similarity to ATP and ADP makes it valuable for studying nucleotide-dependent processes, such as DNA repair and RNA synthesis. Ap?A is also implicated in stress responses and apoptosis regulation. With high purity and stability, it is widely used in biochemical research, particularly in enzymology and molecular biology, to investigate nucleotide interactions and signaling pathways. Its specificity and reactivity make it a useful tool for mechanistic studies.
5959-90-0 structure
Product Name:Adenosine-(5')-triphospho-(5')-adenosine
CAS No:5959-90-0
MF:C20H27N10O16P3
MW:756.407065629959
CID:367989
PubChem ID:165381
Update Time:2025-05-27
Adenosine-(5')-triphospho-(5')-adenosine Chemical and Physical Properties
Names and Identifiers
-
- adenosine 5'-triphosphate 5'-adenosine
- Diadenosine triphosphate
- P1-(5’-ADENOSYL) P3-(5’-ADENOSYL) TRIPHOSPHATE SODIUM SALT
- 5'-ester with adenosine
- Adenosine5'-(tetrahydrogen triphosphate), P''®
- P1,P3- 3 Diadenosine-5' triphosphate
- ApppA
- Ap A
- Adenosine-(5')-triphospho-(5')-adenosine
- Adenosine 5'-triphosphate, 5'-ester with adenosine (7CI)
- Adenosine 5'-(tetrahydrogen triphosphate), P''→5'-ester with adenosine
- GTPL5454
- BDBM50184368
- BIS(ADENOSINE)-5'-TRIPHOSPHATE
- P1,P3-Diadenosine-5 inverted exclamation marka triphosphate
- 5959-90-0
- P(1),P(3)-bis(5'-adenosyl) trihydrogen triphosphate
- adenosine(5'')triphospho(5'')adenosine
- P(1),P(3)-bis(5''-adenosyl) trihydrogen triphosphate
- P(1),P(3)-bis(5''-adenosyl) triphosphate
- CHEBI:27775
- adenosine(5')triphospho(5')adenosine
- {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphinic acid
- D0S5GU
- bis[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate
- Q27074473
- 5'Ap3A
- A(5')p3(5')A
- P1,P3-Bis(5'-adenosyl) triphosphate
- C06197
- P(1),P(3)-bis(5'-adenosyl) trihydrogen triphosphate
- P(1),P(3)-bis(5'-adenosyl) triphosphate
- Ap3A
- Adenosine 5'-(tetrahydrogen triphosphate), P''-5'-ester with adenosine
- CHEMBL407938
- Adenosine (5')triphospho(5')adenosine
- DB01690
- A(5'')p3(5'')A
- SCHEMBL1744586
- ApppA
- Adenosine(3)triphosphate adenosine
- Adenosine-(5')-triphospho-(5')-adenosine
- P1,P3-Diadenosine-5' triphosphate
- NS00070415
- P(1),P(3)-bis(5'-adenosyl) triphosphate
-
- Inchi: 1S/C20H27N10O16P3/c21-15-9-17(25-3-23-15)29(5-27-9)19-13(33)11(31)7(43-19)1-41-47(35,36)45-49(39,40)46-48(37,38)42-2-8-12(32)14(34)20(44-8)30-6-28-10-16(22)24-4-26-18(10)30/h3-8,11-14,19-20,31-34H,1-2H2,(H,35,36)(H,37,38)(H,39,40)(H2,21,23,25)(H2,22,24,26)/t7-,8-,11-,12-,13-,14-,19-,20-/m1/s1
- InChI Key: QCICUPZZLIQAPA-XPWFQUROSA-N
- SMILES: P(=O)(O)(OP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@H](N2C=NC3C(N)=NC=NC2=3)O1)O)O)OC[C@@H]1[C@H]([C@H]([C@H](N2C=NC3C(N)=NC=NC2=3)O1)O)O
Computed Properties
- Exact Mass: 756.08193580g/mol
- Monoisotopic Mass: 756.08193580g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 9
- Hydrogen Bond Acceptor Count: 24
- Heavy Atom Count: 49
- Rotatable Bond Count: 12
- Complexity: 1240
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 8
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: -7.2
- Topological Polar Surface Area: 387?2
Adenosine-(5')-triphospho-(5')-adenosine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | A959900-10mg |
Adenosine-(5')-triphospho-(5')-adenosine |
5959-90-0 | 10mg |
$ 155.00 | 2023-04-19 | ||
| TRC | A959900-50mg |
Adenosine-(5')-triphospho-(5')-adenosine |
5959-90-0 | 50mg |
$ 620.00 | 2023-04-19 | ||
| TRC | A959900-100mg |
Adenosine-(5')-triphospho-(5')-adenosine |
5959-90-0 | 100mg |
$ 1194.00 | 2023-04-19 | ||
| TRC | A959900-mg100 |
Adenosine-(5')-triphospho-(5')-adenosine |
5959-90-0 | mg100 |
$ 990.00 | 2022-07-14 |
Adenosine-(5')-triphospho-(5')-adenosine Production Method
Production Method 1
Reaction Conditions
1.1R:EtN(Pr-i)2, R:PCl3, S:THF, 10 min, 0°C; 45 min, 0°C
2.1R:EtN(Pr-i)2, 10 min, 0°C; 25 min, 0°C
2.2R:EtN(Pr-i)2, S:H2O, 10 min, 0°C; 10 min, 0°C
3.1R:EtN(Pr-i)2, R:PCl3, 10 min, 0°C; 25 min, 0°C
3.2R:EtN(Pr-i)2, 10 min, 0°C; 15 min, 0°C
1.1R:EtN(Pr-i)2, R:PCl3, S:THF, 10 min, 0°C; 45 min, 0°C
2.1R:EtN(Pr-i)2, S:H2O, S:THF, 0°C
2.2R:EtN(Pr-i)2, 10 min, 0°C; 35 min, 0°C
3.1R:(polymer-bound)R:EtN(Pr-i)2, S:THF, 24 h, 4°C
4.1R:S:THF, S:DMSO, 48 h, rt
5.1R:t-BuOOH, S:Me(CH2)8Me, S:THF, 2.5 h, rt
6.1R:DBU, S:THF, 48 h, rt
2.1R:EtN(Pr-i)2, 10 min, 0°C; 25 min, 0°C
2.2R:EtN(Pr-i)2, S:H2O, 10 min, 0°C; 10 min, 0°C
3.1R:EtN(Pr-i)2, R:PCl3, 10 min, 0°C; 25 min, 0°C
3.2R:EtN(Pr-i)2, 10 min, 0°C; 15 min, 0°C
1.1R:EtN(Pr-i)2, R:PCl3, S:THF, 10 min, 0°C; 45 min, 0°C
2.1R:EtN(Pr-i)2, S:H2O, S:THF, 0°C
2.2R:EtN(Pr-i)2, 10 min, 0°C; 35 min, 0°C
3.1R:(polymer-bound)R:EtN(Pr-i)2, S:THF, 24 h, 4°C
4.1R:S:THF, S:DMSO, 48 h, rt
5.1R:t-BuOOH, S:Me(CH2)8Me, S:THF, 2.5 h, rt
6.1R:DBU, S:THF, 48 h, rt
Reference
Production Method 2
Reaction Conditions
1.1R:2-PySSPy-2, R:Et3N, R:PPh3, S:DMF
1.2C:ZnCl2, S:DMF
1.2C:ZnCl2, S:DMF
Reference
- New Journal of Chemistry'Bimetallic Cu2+ complexes of bis-terpyridine ligands as catalysts of the cleavage of mRNA 5'-cap models. The effect of linker length and base moiety' By Maanpaeae, Leena et al, 2009 , vol.33(9), # 4 p.1853-1858
Production Method 3
Reaction Conditions
1.1C:2591-17-5, C:9014-00-0 (firefly), S:H2O
Reference
- Specific synthesis of adenosine(5')tetraphospho(5')nucleoside and adenosine(5')oligophospho(5')adenosine (n > 4) catalyzed by firefly luciferaseBy Ortiz, Begona et al, European Journal of Biochemistry, 1993, 212(1), 263-70
Production Method 4
Reaction Conditions
1.1R:2-PySSPy-2, R:Et3N, R:PPh3, S:DMF
1.2C:ZnCl2, S:DMF
1.2C:ZnCl2, S:DMF
Reference
- Bimetallic Cu2+ complexes of bis-terpyridine ligands as catalysts of the cleavage of mRNA 5'-cap models. The effect of linker length and base moietyBy Maanpaeae, Leena et al, New Journal of Chemistry, 2009, 33(9), 1853-1858
Production Method 5
Production Method 6
Reaction Conditions
1.1R:2-PySSPy-2, R:P(OPh)3, S:DMF, 30 min, -5°C
1.2R:LiClO4, S:Me2CO, 0°C
2.1R:2-PySSPy-2, C:63951-94-0
1.2R:LiClO4, S:Me2CO, 0°C
2.1R:2-PySSPy-2, C:63951-94-0
Reference
- Engineering Human Fhit, a Diadenosine Triphosphate Hydrolase, into an Efficient Dinucleoside Polyphosphate SynthaseBy Huang, Kaisheng and Frey, Perry A., Journal of the American Chemical Society, 2004, 126(31), 9548-9549
Production Method 7
Reaction Conditions
1.1R:MgCl2, R:R:ZnCl2, C:9031-26-9, S:H2O, overnight, rt, pH 7.8
Reference
- 反應(yīng)條件 :
- 1.1R:MgCl2, R:R:ZnCl2, C:9031-26-9, S:H2O, overnight, rt, pH 7.8
- The duality of LysU, a catalyst for both Ap4A and Ap3A formationBy Wright, Michael et al, FEBS Journal, 2006, 273(15), 3534-3544
Production Method 8
Reaction Conditions
1.1C:2591-17-5, C:9014-00-0 (firefly), S:H2O
Reference
- 反應(yīng)條件 :
- 1.1C:2591-17-5, C:9014-00-0 (firefly), S:H2O
- Specific synthesis of adenosine(5')tetraphospho(5')nucleoside and adenosine(5')oligophospho(5')adenosine (n > 4) catalyzed by firefly luciferaseBy Ortiz, Begona et al, European Journal of Biochemistry, 1993, 212(1), 263-70
Production Method 9
Reaction Conditions
1.1R:2-PySSPy-2, R:P(OPh)3, S:DMF, 30 min, -5°C
1.2R:LiClO4, S:Me2CO, 0°C'
2.1R:2-PySSPy-2, C:63951-94-0
1.2R:LiClO4, S:Me2CO, 0°C'
2.1R:2-PySSPy-2, C:63951-94-0
Reference
- Journal of the American Chemical Society'Engineering Human Fhit, a Diadenosine Triphosphate Hydrolase, into an Efficient Dinucleoside Polyphosphate Synthase' By Huang, Kaisheng and Frey, Perry A., 2004 , vol.126(31), # 4 p.9548-9549
Production Method 10
Reaction Conditions
1.1R:EtN(Pr-i)2, R:PCl3, S:THF, 10 min, 0°C; 45 min, 0°C
2.1R:EtN(Pr-i)2, 10 min, 0°C; 25 min, 0°C
2.2R:EtN(Pr-i)2, S:H2O, 10 min, 0°C; 10 min, 0°C
3.1R:EtN(Pr-i)2, R:PCl3, 10 min, 0°C; 25 min, 0°C
3.2R:EtN(Pr-i)2, 10 min, 0°C; 15 min, 0°C
1.1R:EtN(Pr-i)2, R:PCl3, S:THF, 10 min, 0°C; 45 min, 0°C
2.1R:EtN(Pr-i)2, S:H2O, S:THF, 0°C
2.2R:EtN(Pr-i)2, 10 min, 0°C; 35 min, 0°C
3.1R:(polymer-bound)R:EtN(Pr-i)2, S:THF, 24 h, 4°C
4.1R:S:THF, S:DMSO, 48 h, rt
5.1R:t-BuOOH, S:Me(CH2)8Me, S:THF, 2.5 h, rt
6.1R:DBU, S:THF, 48 h, rt
2.1R:EtN(Pr-i)2, 10 min, 0°C; 25 min, 0°C
2.2R:EtN(Pr-i)2, S:H2O, 10 min, 0°C; 10 min, 0°C
3.1R:EtN(Pr-i)2, R:PCl3, 10 min, 0°C; 25 min, 0°C
3.2R:EtN(Pr-i)2, 10 min, 0°C; 15 min, 0°C
1.1R:EtN(Pr-i)2, R:PCl3, S:THF, 10 min, 0°C; 45 min, 0°C
2.1R:EtN(Pr-i)2, S:H2O, S:THF, 0°C
2.2R:EtN(Pr-i)2, 10 min, 0°C; 35 min, 0°C
3.1R:(polymer-bound)R:EtN(Pr-i)2, S:THF, 24 h, 4°C
4.1R:S:THF, S:DMSO, 48 h, rt
5.1R:t-BuOOH, S:Me(CH2)8Me, S:THF, 2.5 h, rt
6.1R:DBU, S:THF, 48 h, rt
Reference
- Organic Letters'Solid-Phase Synthesis of Symmetrical 5',5'-Dinucleoside Mono-, Di-, Tri-, and Tetraphosphodiesters' By Ahmadibeni, Yousef and Parang, Keykavous, 2007 , vol.9(22), # 4 p.4483-4486
Adenosine-(5')-triphospho-(5')-adenosine Raw materials
- 3-hydroxypropanenitrile
- Imidazole
- Adenosine 5'-(trihydrogen diphosphate), magnesium salt (1:1)
- Adenosine 5′-(trihydrogen diphosphate), compd. with N,N-diethylethanamine (1:2)
- Adenosine 5'-Triphosphate
- Adenosine monophosphate
- Adenosine
- 5'-Adenylic acid, compd. with N,N-diethylethanamine (1:1)
Adenosine-(5')-triphospho-(5')-adenosine Preparation Products
- Adenosine 5'-(hexahydrogen pentaphosphate), P''''→5'-ester with adenosine (41708-91-2)
- Adenosine-(5')-triphospho-(5')-adenosine (5959-90-0)
- Adenosine octaphosphate (109345-26-8)
- Adenosine 5'-(dodecahydrogen undecaphosphate), P''''''''''→5'-ester with adenosine (9CI) (148503-97-3)
- Adenosine 5'-(tridecahydrogen dodecaphosphate), P'''''''''''→5'-ester with adenosine (9CI) (148503-99-5)
- Adenosine 5'-(heneicosahydrogen eicosaphosphate) (9CI) (148504-10-3)
Adenosine-(5')-triphospho-(5')-adenosine Suppliers
NewCan Biotech Limited
Gold Member
(CAS:5959-90-0)Adenosine-(5')-triphospho-(5')-adenosine
Order Number:NC13242
Stock Status:
Quantity:10g
Purity:97%
Pricing Information Last Updated:Friday, 18 July 2025 16:04
Price ($):Price inquiry
Email:[email protected]
Adenosine-(5')-triphospho-(5')-adenosine Related Literature
-
Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
-
Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
-
Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
-
Jason Wan Lab Chip, 2020,20, 4528-4538
-
Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
5959-90-0 (Adenosine-(5')-triphospho-(5')-adenosine) Related Products
- 102783-36-8(P1,P4-Di(adenosine-5’) Tetraphosphate Ammonium Salt)
- 1062-98-2(Adenosine 5'-(pentahydrogen tetraphosphate))
- 1476-84-2(Adenosine 5'-(tetrahydrogen triphosphate) magnesium salt)
- 56-65-5(Adenosine 5'-Triphosphate)
- 987-65-5(Adenosine 5-triphosphate, disodium salt)
- 117405-91-1(Rhodate(1-), [adenosine5'-(triphosphato)(4-)-kOP',kOP'']tetraaqua-, hydrogen,[OC-6-33-(S)]- (9CI))
- 11016-17-4(R-PHYCOERYTHRIN)
- 102185-19-3(adenosine 5'-triphosphate di(monoethanolammonium) salt)
- 102783-34-6(Adenosine5'-(heptahydrogen hexaphosphate), P'''''®5'-ester with adenosine, hexaammonium salt (9CI))
- 102783-40-4(Adenosine5'-(tetrahydrogen triphosphate), P''®5'-ester with adenosine, triammonium salt (9CI))
Recommended suppliers
NewCan Biotech Limited
(CAS:5959-90-0)Adenosine-(5')-triphospho-(5')-adenosine
Purity:97%
Quantity:10g
Price ($):Inquiry